We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis

By LabMedica International staff writers
Posted on 18 Jul 2025

Cardiovascular disease is the leading cause of death worldwide, and atherosclerosis plays a critical role in its development. More...

This chronic condition, characterized by the hardening and narrowing of arteries due to the accumulation of fat deposits and inflammation, poses challenges in early detection. Clinical practice currently focuses on factors like cholesterol, hypertension, and smoking, but diagnosing atherosclerosis in its early stages remains difficult.

The issue is compounded by the reliance on advanced imaging techniques, which are complex, expensive, and not always covered by public health systems. Researchers have now discovered that a specific metabolite in the blood, Imidazole propionate (ImP), is linked to the early stages of active atherosclerosis, providing a potential diagnostic marker for detecting the disease in individuals who otherwise appear healthy.

In a new study, researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC, Madrid, Spain) showed that ImP, a metabolite produced by intestinal bacteria, is elevated in individuals with atherosclerosis. Through extensive research, it was found that ImP not only serves as a marker for the disease but also plays a causal role in its development. In animal models, the administration of ImP resulted in the formation of arterial plaques by activating the imidazoline receptor type 1 (I1R), which triggers systemic inflammation and promotes atherosclerosis.

The research team also discovered that blocking the I1R receptor in mice fed a high-cholesterol diet slowed the progression of the disease, opening up new possibilities for treatment. These findings suggest that targeting ImP and I1R could be an effective strategy in preventing or treating atherosclerosis. The findings, published in Nature, support early detection of this metabolite in blood as a new diagnostic tool and open the door to personalized treatment strategies. Researchers are now working on developing drugs that block the detrimental effects of ImP, which could be combined with cholesterol-lowering drugs for a synergistic effect.

“These findings open new possibilities for the early detection and personalized treatment of atherosclerosis,” said David Sancho, head of the CNIC Immunobiology Laboratory and lead author on the study. “Instead of focusing solely on cholesterol and other classic risk factors, we may soon be able to analyze blood for ImP as an early warning signal.”

Related Links:
CNIC


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.